BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 33145294)

  • 21. The minimum number of examined lymph nodes was 24 for optimal survival of pathological T2-4 gastric cancer: a multi-center, hospital-based study covering 20 years of data.
    Zhao L; Zhang F; Jiao F; Zhou X; Niu P; Han X; Wang W; Luan X; He M; Guan Q; Li Y; Zhao D; Gao J; Chen Y
    BMC Cancer; 2023 Sep; 23(1):892. PubMed ID: 37735628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Examined Lymph Node Count on Precise Staging and Long-term Survival After Neoadjuvant Therapy for Carcinoma of the Esophagus: A SEER Database Analysis.
    Bao T; Bao L; Guo W
    Front Surg; 2022; 9():864593. PubMed ID: 35574562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of examined lymph node count on prognosis in patients with lymph node-negative pancreatic body/tail ductal adenocarcinoma.
    Li YF; Xiang YC; Zhang QQ; Wang WL
    J Gastrointest Oncol; 2020 Aug; 11(4):644-653. PubMed ID: 32953148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The minimum number of examined lymph nodes for accurate nodal staging and optimal survival of stage T1-2 esophageal squamous cell carcinoma: A retrospective multicenter cohort with SEER database validation.
    Tian D; Li HX; Yang YS; Yan HJ; Jiang KY; Zheng YB; Zong ZD; Zhang HL; Guo XG; Wen HY; Chen LQ
    Int J Surg; 2022 Aug; 104():106764. PubMed ID: 35803513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of the Extent of Lymph Node Dissection on Precise Staging and Survival in Clinical I-II Pure-Solid Lung Cancer Undergoing Lobectomy.
    Chen D; Mao Y; Wen J; Shu J; Ye F; She Y; Ding Q; Shi L; Xue T; Fan M; Chen Y; Chen C
    J Natl Compr Canc Netw; 2021 Apr; 19(4):393-402. PubMed ID: 33508774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of examined lymph node count on survival in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
    Zhou J; Zhang WW; Wu SG; He ZY; Sun JY; Wang Y; Chen QH
    Cancer Manag Res; 2017; 9():315-322. PubMed ID: 28761376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of examined lymph-node count in accurate staging and long-term survival in patients undergoing radical prostatectomy: a population-based study.
    Chen C; Shen J; Xing Z; Jiang C; Hu L; Cui L; Xue D; He X; Xu R
    Int Urol Nephrol; 2020 Feb; 52(2):271-278. PubMed ID: 31571158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel Criterion for Lymph Nodes Dissection in Distal Pancreatectomy for Ductal Adenocarcinoma: A Population Study of the US SEER Database.
    Wang W; Shen Z; Zhang J; Chen H; Deng X; Peng C; Xie J; Xu Z; Shen B
    Ann Surg Oncol; 2022 Mar; 29(3):1533-1539. PubMed ID: 34622372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients.
    Xie J; Pang Y; Li X; Wu X
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2259-2269. PubMed ID: 34003367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of metastatic lymph node ratio in patients with gastric cancer after curative gastrectomy: a single-center retrospective study.
    He Z; Li D; Xu Y; Wang H; Gao J; Zhang Z; Chen K
    Scand J Gastroenterol; 2022 Jul; 57(7):832-841. PubMed ID: 35293268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and Validation of Prognostic Nomograms Based on Lymph Node Ratio for Young Patients with Gastric Cancer: A SEER-Based Study.
    Chen YR; Tian ZY; Wang MQ; Sun ML; Wu JZ; Wang XY
    Technol Cancer Res Treat; 2023; 22():15330338231157923. PubMed ID: 37248609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphadenectomy and optimal excise lymph nodes count for early-stage primary fallopian tube cancer: a SEER-based study.
    Liu Y; Huang F; Gu Q; Wang J; Wang Q; Wu Y; Li L; Xiao Y
    BMC Womens Health; 2023 Dec; 23(1):681. PubMed ID: 38129825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing the Number of Examined Lymph Nodes is a Prerequisite for Improvement in the Accurate Evaluation of Overall Survival of Node-Negative Gastric Cancer Patients.
    Deng J; Yamashita H; Seto Y; Liang H
    Ann Surg Oncol; 2017 Mar; 24(3):745-753. PubMed ID: 27770340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Revolutionizing T3-4N0-2M0 gastric cancer staging with an innovative pN classification system.
    Yin K; Jin X; Pan Y; Zi M; Zheng Y; Ma Y; Pang C; Liu K; Chen J; Wei Y; Liu D; Cheng X; Yuan L
    J Gastrointest Surg; 2024 May; ():. PubMed ID: 38821213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exceeding 30 ELNs is strongly recommended for pT3-4N0 patients with gastric cancer: A multicenter study of survival, recurrence, and prediction model.
    Zhao L; Han W; Yang X; Zhao D; Niu P; Gao X; Wu Z; Zhang X; Li Z; Ji G; Chen Y
    Cancer Sci; 2021 Aug; 112(8):3266-3277. PubMed ID: 34080256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of lymph node density on cancer staging system for gastric cancer without distal metastasis: a population-based analysis of SEER database.
    Liu Y; Cui H; Xu X; Liang W
    World J Surg Oncol; 2022 Sep; 20(1):325. PubMed ID: 36175896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and validation of a Surveillance, Epidemiology, and End Results (SEER)-based prognostic nomogram for predicting survival in gastric cancer with multi-organ metastases.
    Wang T; Liu C; Wang W; Huang B; Yu R; Huang M; Dong W
    Transl Cancer Res; 2022 Jun; 11(6):1534-1551. PubMed ID: 35836507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Impact of the Number of Examined Lymph Nodes in Stage II Colorectal Adenocarcinoma: A Retrospective Study.
    Lei P; Ruan Y; Liu J; Zhang Q; Tang X; Wu J
    Gastroenterol Res Pract; 2020; 2020():8065972. PubMed ID: 32676106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Significance of Lymph Node Count Removed at Sublobar Resection in Pathologic Stage IA Non-Small-cell Lung Cancer: A Population-Based Analysis.
    He Z; Li Z; Xu S; Wu W; Zhu Q; Wang J; Wen W; Chen L
    Clin Lung Cancer; 2021 Jul; 22(4):e563-e573. PubMed ID: 33214078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic impact of examined lymph-node count for patients with esophageal cancer: development and validation prediction model.
    Yuan S; Wei C; Wang M; Deng W; Zhang C; Li N; Luo S
    Sci Rep; 2023 Jan; 13(1):476. PubMed ID: 36627338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.